Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 7, 2008, Pages 736-742

  Van Doorn, H Rogier ^a,b   An, D D ^b   De Jong, M D ^b   Lan, N T N ^c   Hoa, D V ^c   Quy, H T ^c   Chau, N V V ^d   Duy, P M ^b   Tho, D Q ^b   Chinh, N T ^d   Farrar, J J ^b   Caws, M ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^c Pham Ngoc Thach Hospital   (Viet Nam)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Fluoroquinolones; Gyrase; Mycobacteria; Real time PCR; Tuberculosis

Indexed keywords

GENE PRODUCT; GYRASE A; LOCKED NUCLEIC ACID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; GENE MUTATION; GENE SEQUENCE; GOLD STANDARD; GYRA GENE; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID PROBE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY AND SPECIFICITY; WILD TYPE;

EID: 47149107265     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ginsburg A S, Grosset J H, Bishai W R. Fluoroquinolones, tuberculosis and resistance. Lancet Infect Dis 2003; 3: 432-442.
2. Quy H T, Buu T N, Cobelens F G, Lan N T, Lambregts C S, Borgdorff M W. Drug resistance among smear-positive tuberculosis patients in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2006; 10: 160-166.
3. Takiff H E, Salazar L, Guerrero C, et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 1994; 38: 773-780.
4. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 179-192.
5. Aubry A, Veziris N, Cambau E, Truffot-Pernot C, Jarlier V, Fisher L M. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother 2006; 50: 104-112.
6. Williams K J, Chan R, Piddock L J. GyrA of ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Hong Kong. J Antimicrob Chemother 1996; 37: 1032-1034.
7. Siddiqi N, Shamim M, Hussain S, et al. Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 2002; 46: 443-450.
8. Cheng A F, Yew W W, Chan E W, Chin M L, Hui M M, Chan R C. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2004; 48: 596-601.
9. Post F A, Willcox P A, Mathema B, et al. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis 2004; 190: 99-106.
10. Huang T S, Kunin C M, Shin-Jung Lee S, Chen Y S, Tu H Z, Liu Y C. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003. J Antimicrob Chemother 2005; 56: 1058-1062.
11. Matrat S, Veziris N, Mayer C, et al. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones. Antimicrob Agents Chemother 2006; 50: 4170-4173.
12. Kutyavin I V, Afonina I A, Mills A, et al. 3′-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 2000; 28: 655-661.
13. Ugozzoli L A, Latorra D, Puckett R, Arar K, Hamby K. Real-time genotyping with oligonucleotide probes containing locked nucleic acids. Anal Biochem 2004; 324: 143-152.
14. World Health Organization/International Union against Tuberculosis and Lung Diseases. Anti-tuberculosis drug resistance in the world. 3rd global report. WHO/HTM/TB/2004.343. Geneva, Switzerland: WHO, 2004.
15. Levy-Frebault V V, Portaels F. Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol 1992; 42: 315-323.
16. Wilson K. Preparation of genomic DNA from bacteria. In: Ausubel F M, Brent R, Kingston R E, et al, eds. Current protocols in molecular biology. 2nd ed. New York, NY, USA: Greene Publishing and Wiley Interscience, 1990.
17. SantaLucia J, Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Nat Acad Sci USA 1998; 95: 1460-1465.
18. Sambrook J, Russell D W. Molecular cloning: a laboratory manual. 3rd ed. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press, 2001.
19. Zhou J, Dong Y, Zhao X, et al. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis 2000; 182: 517-525.
20. Heep M, Brandstatter B, Rieger U, et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 107-110.
21. Rinder H, Mieskes K T, Loscher T. Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2001; 5: 339-345.
22. Yesilkaya H, Meacci F, Niemann S, et al. Evaluation of molecular-beacon, TaqMan, and fluorescence resonance energy transfer probes for detection of antibiotic resistance-conferring single nucleotide polymorphisms in mixed Mycobacterium tuberculosis DNA extracts. J Clin Microbiol 2006; 44: 3826-3829.
23. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 2003; 51: 1109-1117.
24. Giannoni F, Iona E, Sementilli F, et al. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2005; 49: 2928-2933.
25. Shi R, Otomo K, Yamada H, Tatsumi T, Sugawara I. Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes Infect 2006; 8: 128-135.
26. Shi R, Zhang J, Li C, Kazumi Y, Sugawara I. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J Clin Microbiol 2006; 44: 4566-4568.